Cargando…

A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)

BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santangelo, Luisa, Gigante, Maddalena, Netti, Giuseppe Stefano, Diella, Sterpeta, Puteo, Flora, Carbone, Vincenza, Grandaliano, Giuseppe, Giordano, Mario, Gesualdo, Loreto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973878/
https://www.ncbi.nlm.nih.gov/pubmed/24589093
http://dx.doi.org/10.1186/1471-2369-15-41
_version_ 1782479385913196544
author Santangelo, Luisa
Gigante, Maddalena
Netti, Giuseppe Stefano
Diella, Sterpeta
Puteo, Flora
Carbone, Vincenza
Grandaliano, Giuseppe
Giordano, Mario
Gesualdo, Loreto
author_facet Santangelo, Luisa
Gigante, Maddalena
Netti, Giuseppe Stefano
Diella, Sterpeta
Puteo, Flora
Carbone, Vincenza
Grandaliano, Giuseppe
Giordano, Mario
Gesualdo, Loreto
author_sort Santangelo, Luisa
collection PubMed
description BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical and genetic diagnosis of a 5-years old girl with SIOD, referred to our Center because of nephrotic-range proteinuria occasionally detected during the follow-up for congenital hypothyroidism. Mutational analysis of SMARCAL1 gene was performed by polymerase chain reaction (PCR) and bidirectional sequencing. Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*). CONCLUSION: This report provided the clinical and genetic description of a mild phenotype of Schimke immuno-osseous dysplasia associated with nephrotic proteinuria, decreasing after combined therapy with ACE inhibitors and sartans. Our experience highlighted the importance of detailed clinical evaluation, appropriate genetic counseling and molecular testing, to provide timely treatment and more accurate prognosis.
format Online
Article
Text
id pubmed-3973878
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39738782014-04-04 A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) Santangelo, Luisa Gigante, Maddalena Netti, Giuseppe Stefano Diella, Sterpeta Puteo, Flora Carbone, Vincenza Grandaliano, Giuseppe Giordano, Mario Gesualdo, Loreto BMC Nephrol Case Report BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical and genetic diagnosis of a 5-years old girl with SIOD, referred to our Center because of nephrotic-range proteinuria occasionally detected during the follow-up for congenital hypothyroidism. Mutational analysis of SMARCAL1 gene was performed by polymerase chain reaction (PCR) and bidirectional sequencing. Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*). CONCLUSION: This report provided the clinical and genetic description of a mild phenotype of Schimke immuno-osseous dysplasia associated with nephrotic proteinuria, decreasing after combined therapy with ACE inhibitors and sartans. Our experience highlighted the importance of detailed clinical evaluation, appropriate genetic counseling and molecular testing, to provide timely treatment and more accurate prognosis. BioMed Central 2014-03-03 /pmc/articles/PMC3973878/ /pubmed/24589093 http://dx.doi.org/10.1186/1471-2369-15-41 Text en Copyright © 2014 Santangelo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Santangelo, Luisa
Gigante, Maddalena
Netti, Giuseppe Stefano
Diella, Sterpeta
Puteo, Flora
Carbone, Vincenza
Grandaliano, Giuseppe
Giordano, Mario
Gesualdo, Loreto
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title_full A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title_fullStr A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title_full_unstemmed A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title_short A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
title_sort novel smarcal1 mutation associated with a mild phenotype of schimke immuno-osseous dysplasia (siod)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973878/
https://www.ncbi.nlm.nih.gov/pubmed/24589093
http://dx.doi.org/10.1186/1471-2369-15-41
work_keys_str_mv AT santangeloluisa anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT gigantemaddalena anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT nettigiuseppestefano anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT diellasterpeta anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT puteoflora anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT carbonevincenza anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT grandalianogiuseppe anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT giordanomario anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT gesualdoloreto anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT santangeloluisa novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT gigantemaddalena novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT nettigiuseppestefano novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT diellasterpeta novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT puteoflora novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT carbonevincenza novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT grandalianogiuseppe novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT giordanomario novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod
AT gesualdoloreto novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod